Literature DB >> 22076661

Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population.

Maria Bygdell1, Gertrud Brunlöf, Susanna M Wallerstedt, Jenny M Kindblom.   

Abstract

PURPOSE: Psychiatric Adverse Drug Reactions (ADRs) are frequent in the pediatric population. The aim of the present study was to analyze spontaneously reported psychiatric ADRs in children during a 10-year period.
METHODS: All spontaneously reported Individual Case Safety Reports (ICSRs) concerning children (<18 years old) and psychiatric adverse reactions assessed as at least possible, registered in the Swedish Drug Information System (SWEDIS) during the period 2001-2010, were extracted and characterized. Age and sex distribution and labeling/registration status were studied.
RESULTS: A total of 600 ICSRs concerning 744 psychiatric adverse reactions were identified and included in the analysis. Boys were overrepresented among included ICSRs (60.3% vs. 39.7%; p < .001). After exclusion of vaccines, the three most frequently suspected drugs were montelukast, centrally working sympathomimetic drugs, and inhaled glucocorticoids. Serious adverse reactions were reported more frequently for drugs used off-label than for drugs used according to the Swedish Physician's Desk Reference. Aggressiveness was reported more frequently for boys than for girls as were suicidal conditions.
CONCLUSIONS: Psychiatric ADRs in the pediatric population have been reported for a wide range of reactions and drugs and display age and sex differences including a higher number of suicidal reactions in boys. An association was seen between serious reactions and off-label drug use. Further studies are needed to elucidate safety aspects of unlicensed drugs and drugs used off-label and whether there are differences in children's susceptibility to develop ADRs.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076661     DOI: 10.1002/pds.2265

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  13 in total

1.  Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.

Authors:  Brigitte Benard; Valérie Bastien; Benjamin Vinet; Roger Yang; Maja Krajinovic; Francine M Ducharme
Journal:  Eur Respir J       Date:  2017-08-17       Impact factor: 16.671

2.  Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase(®).

Authors:  Ana Aldea Perona; Mar García-Sáiz; Emilio Sanz Álvarez
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

3.  A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development.

Authors:  Nicholas P Giangreco; Nicholas P Tatonetti
Journal:  Med (N Y)       Date:  2022-06-24

4.  Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011.

Authors:  Kyla H Thomas; Richard M Martin; John Potokar; Munir Pirmohamed; David Gunnell
Journal:  BMC Pharmacol Toxicol       Date:  2014-09-30       Impact factor: 2.483

5.  A tool to utilize adverse effect profiles to identify brain-active medications for repurposing.

Authors:  Thomas H McCoy; Roy H Perlis
Journal:  Int J Neuropsychopharmacol       Date:  2015-02-11       Impact factor: 5.176

6.  Pediatric drug safety signal detection: a new drug-event reference set for performance testing of data-mining methods and systems.

Authors:  Osemeke U Osokogu; Federica Fregonese; Carmen Ferrajolo; Katia Verhamme; Sandra de Bie; Geert 't Jong; Mariana Catapano; Daniel Weibel; Florentia Kaguelidou; Wichor M Bramer; Yingfen Hsia; Ian C K Wong; Madlen Gazarian; Jan Bonhoeffer; Miriam Sturkenboom
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

7.  Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS).

Authors:  Sainan Bian; Lisha Li; Zixi Wang; Le Cui; Yingyang Xu; Kai Guan; Bin Zhao; Lianglu Wang; Jia Yin
Journal:  World Allergy Organ J       Date:  2021-10-01       Impact factor: 4.084

8.  Sleeptalking! Sleepwalking! Side effects of montelukast.

Authors:  Samer Alkhuja; Natalya Gazizov; Mary Ellen Alexander
Journal:  Case Rep Pulmonol       Date:  2013-09-05

9.  Side Effects of Leukotriene Receptor Antagonists in Asthmatic Children.

Authors:  Semiha Bahceci Erdem; Hikmet Tekin Nacaroglu; Canan Sule Unsal Karkiner; Ilker Gunay; Demet Can
Journal:  Iran J Pediatr       Date:  2015-10-06       Impact factor: 0.364

10.  The anti-asthmatic drug, montelukast, modifies the neurogenic potential in the young healthy and irradiated brain.

Authors:  Yohanna Eriksson; Martina Boström; Åsa Sandelius; Kaj Blennow; Henrik Zetterberg; Georg Kuhn; Marie Kalm
Journal:  Cell Death Dis       Date:  2018-07-10       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.